Current colorectal cancer screening strategies: Overview and obstacles to implementation

Douglas Rex

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Colorectal cancer is the second leading cause of cancer death but is largely preventable. Current strategies to prevent colorectal cancer vary considerably with regard to effectiveness, up-front costs, risks, and invasiveness. Current levels of participation in colorectal cancer screening in the U.S. population are low. Both physician and patient attitudes contribute to low levels of screening uptake. New colorectal cancer tests are one mechanism to improve adherence. Virtual colonoscopy may have an important impact if techniques to perform it without bowel preparation can be developed. Stool-based DNA testing is likely to be the most effective entirely noninvasive strategy and will be easier for patients to perform than fecal occult blood testing. The potential for improvements in the technology are substantial, and data from second-generation assays have already been reported. The cost-effectiveness of new strategies needs further evaluation.

Original languageEnglish
JournalReviews in Gastroenterological Disorders
Volume2
Issue numberSUPPL. 1
StatePublished - 2002

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
Computed Tomographic Colonography
Occult Blood
Cost-Benefit Analysis
Cause of Death
Technology
Physicians
Costs and Cost Analysis
DNA
Population
Neoplasms

Keywords

  • Colorectal cancer
  • Double contrast barium enema
  • Fecal occult blood testing
  • Sigmoidoscopy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Current colorectal cancer screening strategies : Overview and obstacles to implementation. / Rex, Douglas.

In: Reviews in Gastroenterological Disorders, Vol. 2, No. SUPPL. 1, 2002.

Research output: Contribution to journalArticle

@article{e6e2834b4deb4436ae28fb1e59cb5bfb,
title = "Current colorectal cancer screening strategies: Overview and obstacles to implementation",
abstract = "Colorectal cancer is the second leading cause of cancer death but is largely preventable. Current strategies to prevent colorectal cancer vary considerably with regard to effectiveness, up-front costs, risks, and invasiveness. Current levels of participation in colorectal cancer screening in the U.S. population are low. Both physician and patient attitudes contribute to low levels of screening uptake. New colorectal cancer tests are one mechanism to improve adherence. Virtual colonoscopy may have an important impact if techniques to perform it without bowel preparation can be developed. Stool-based DNA testing is likely to be the most effective entirely noninvasive strategy and will be easier for patients to perform than fecal occult blood testing. The potential for improvements in the technology are substantial, and data from second-generation assays have already been reported. The cost-effectiveness of new strategies needs further evaluation.",
keywords = "Colorectal cancer, Double contrast barium enema, Fecal occult blood testing, Sigmoidoscopy",
author = "Douglas Rex",
year = "2002",
language = "English",
volume = "2",
journal = "Reviews in Gastroenterological Disorders",
issn = "1533-001X",
publisher = "MedReviews LLC",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Current colorectal cancer screening strategies

T2 - Overview and obstacles to implementation

AU - Rex, Douglas

PY - 2002

Y1 - 2002

N2 - Colorectal cancer is the second leading cause of cancer death but is largely preventable. Current strategies to prevent colorectal cancer vary considerably with regard to effectiveness, up-front costs, risks, and invasiveness. Current levels of participation in colorectal cancer screening in the U.S. population are low. Both physician and patient attitudes contribute to low levels of screening uptake. New colorectal cancer tests are one mechanism to improve adherence. Virtual colonoscopy may have an important impact if techniques to perform it without bowel preparation can be developed. Stool-based DNA testing is likely to be the most effective entirely noninvasive strategy and will be easier for patients to perform than fecal occult blood testing. The potential for improvements in the technology are substantial, and data from second-generation assays have already been reported. The cost-effectiveness of new strategies needs further evaluation.

AB - Colorectal cancer is the second leading cause of cancer death but is largely preventable. Current strategies to prevent colorectal cancer vary considerably with regard to effectiveness, up-front costs, risks, and invasiveness. Current levels of participation in colorectal cancer screening in the U.S. population are low. Both physician and patient attitudes contribute to low levels of screening uptake. New colorectal cancer tests are one mechanism to improve adherence. Virtual colonoscopy may have an important impact if techniques to perform it without bowel preparation can be developed. Stool-based DNA testing is likely to be the most effective entirely noninvasive strategy and will be easier for patients to perform than fecal occult blood testing. The potential for improvements in the technology are substantial, and data from second-generation assays have already been reported. The cost-effectiveness of new strategies needs further evaluation.

KW - Colorectal cancer

KW - Double contrast barium enema

KW - Fecal occult blood testing

KW - Sigmoidoscopy

UR - http://www.scopus.com/inward/record.url?scp=0036287605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036287605&partnerID=8YFLogxK

M3 - Article

C2 - 12439393

AN - SCOPUS:0036287605

VL - 2

JO - Reviews in Gastroenterological Disorders

JF - Reviews in Gastroenterological Disorders

SN - 1533-001X

IS - SUPPL. 1

ER -